Hepatic Cell News Volume 7.03 | Jan 27 2023

    0
    18








    2023-01-27 | HCN 7.03


    Hepatic Cell News by STEMCELL Technologies
    Vol. 7.03 – 27 January, 2023
    TOP STORY

    The Transcription Factor ATF3 Switches Cell Death from Apoptosis to Necroptosis in Hepatic Steatosis in Male Mice

    The authors show that hepatic steatosis aggravation shifts the hepatocellular death mode from apoptosis to necroptosis, causing increased hepatocellular death.
    [Nature Communications]

    Full Article
    Virtual Conference Exhibition: Pluripotent Stem Cells
    PUBLICATIONSRanked by the impact factor of the journal

    Tuning the Corona-Core Ratio of Polyplex Micelles for Selective Oligonucleotide Delivery to Hepatocytes or Hepatic Immune Cells

    Applying Raman-spectroscopy and dynamic in silico modeling on the polyplex micelles, researchers determined the corona-core ratio (CCR) and visualized the possible micellar structure with varying CCR.
    [Biomaterials]

    Full ArticleGraphical Abstract

    Experimental and Computational Studies of Silver(I) Dibenzoylmethane-Based Complexes, Interaction with DNA/RNA/BSA Biomolecules, and In Vitro Cytotoxic Activity

    Ag(I) ion was found to be coordinated with the ligand’s oxygens in almost a linear fashion in complex, while in complex it adopted a tetrahedral geometry.
    [Journal Of Inorganic Biochemistry]

    Abstract

    Exosomes Derived from Human Adipose Mesenchymal Stem Cells Ameliorate Hepatic Fibrosis by Inhibiting PI3K/Akt/mTOR Pathway and Remodeling Choline Metabolism

    The authors investigated anti-fibrotic efficacy of exosomes derived from human adipose MSCs in vitro and in vivo, and identified important metabolic changes and the detailed mechanism through transcriptomic and metabolomic profiling.
    [Journal Of Nanobiotechnology]

    AbstractGraphical Abstract

    Hepatic TNFRSF12A Promotes Bile Acid-Induced Hepatocyte Pyroptosis through NFκB/Caspase-1/GSDMD Signaling in Cholestasis

    Human hepatoma PLC/PRF/5-ASBT and THP1 cell lines or primary mouse hepatocytes were used for mechanistic studies. Hepatic TNFRSF12A expression was markedly increased in obstructive cholestasis or primary biliary cholangitis patients.
    [Cell Death Discovery]

    Full Article

    EGFR and Lyn Inhibition Augments Regorafenib Induced Cell Death in Sorafenib Resistant 3D Tumor Spheroid Model

    Investigators utilized sorafenib resistant Huh7 cell line and LX2 hepatic stellate cell line to establish a sorafenib resistant 3D tumor spheroid model which could be used to test second-line treatment options.
    [Cellular Signalling]

    AbstractGraphical Abstract

    YAP1 Suppression Inhibits Autophagy and Improves the Efficacy of Anti-PD-1 Immunotherapy in Hepatocellular Carcinoma

    YAP1 expression and autophagy constituted positive feedback, in which YAP1 inhibition decreased the autophagy activity in liver tumor cells by hepatocyte-specific Yap1 knockout mice.
    [Experimental Cell Research]

    Full ArticleGraphical Abstract

    NFYAv1 is a Tumor-Promoting Transcript Associated with Poor Prognosis of Hepatocellular Carcinoma

    RNA-seq data from the Genotype-Tissue Expression Project and TCGA were analyzed in combination. In vitro cellular and molecular studies were conducted using SK-Hep-1 and Hep3B cells.
    [Medical Science Monitor]

    Full Article

    An Unconventional Cancer-Promoting Function of Methamphetamine in Hepatocellular Carcinoma

    Scientists found a higher HCC incidence in methamphetamine (METH) abusers. METH promoted cellular proliferation, migration, and invasion in two human-derived HCC cells.
    [Life Science Alliance]

    Full Article
    Explore the Science Events Calendar to discover conferences, podcasts, webinars, and more!
    REVIEWS

    Cell and Cell-Derivative-Based Therapy for Liver Diseases; Current Approaches and Future Promises

    Owing to several shortcomings like finite numbers of healthy organ donors, lifelong immunosuppression, and complexity of orthotopic liver transplantation, cell and cell-derivities therapies have emerged as a potential therapeutic alternative for a broad range of liver diseases.
    [Expert Review Of Gastroenterology & Hepatology]

    Abstract

    Roles of Protein Tyrosine Phosphatases in Hepatocellular Carcinoma Progression

    Scientists discuss the relationship of protein tyrosine phosphatases (PTPs) with inflammatory cytokines and chemotherapy/targeted drug resistance, providing detailed information on how PTPs can modulate inflammatory reactions and drug resistance to influence progression in HCC.
    [Oncology Reports]

    Abstract
    INDUSTRY AND POLICY NEWS

    Damon Runyon Cancer Research Foundation Awards over $4.3M to Top Young Scientists

    The Damon Runyon Cancer Research Foundation announced its newest class of Damon Runyon Fellows, 14 exceptional postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators.
    [Damon Runyon Cancer Research Foundation]

    Press Release
    FEATURED EVENT

    AACR Annual Meeting 2023

    April 14 – 19, 2023
    Orlando, Florida, United States

    > See All Events

    JOB OPPORTUNITIES

    Director – Liver Disease Research

    Takeda Pharmaceutical Company – Boston, Massachusetts, United States

    Research Associate – CAR T Immunotherapy

    Imperial College London – London, United Kingdom

    Research Associate – Digestion and Liver

    UT Southwestern Medical Center – Dallas, Texas, United States

    Postdoctoral Research Fellow – Liver Organoids

    Cincinnati Children’s Hospital Medical Center – Cincinnati, Ohio, United States

    Postdoctoral Scientist – Cell Biology

    MRC National Institute for Medical Research – Cambridge, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter